SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-042887
Filing Date
2024-02-22
Accepted
2024-02-22 16:37:03
Documents
15
Period of Report
2024-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d793484d8k.htm   iXBRL 8-K 27280
  Complete submission text file 0001193125-24-042887.txt   190987

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sybx-20240217.xsd EX-101.SCH 3544
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sybx-20240217_def.xml EX-101.DEF 14623
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20240217_lab.xml EX-101.LAB 24080
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20240217_pre.xml EX-101.PRE 15531
17 EXTRACTED XBRL INSTANCE DOCUMENT d793484d8k_htm.xml XML 6030
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 24665481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)